Distribution of Molnupiravir Drug Started

Minister of Health Fahrettin Koca, who attended the opening ceremony of Aksu Training and Research Hospital in Giresun in the past weeks, made some statements about the coronavirus. About the coronavirus, which has been in our lives for more than two years, “The precaution is now personal. As your Minister of Health, I say the loudest that the increasing number of cases should not frighten you; do not worry, the disease is not as strong as it used to be.” Koca also made statements about the developments in our country regarding the epidemic.

Coronavirus Scientific Committee meeting was held this evening with the participation of Health Minister Fahrettin Koca. After the meeting, it was announced that drugs will be distributed to citizens aged 65 and over and immunocompromised. In the statement made, information was also given about the local vaccine and the general course of the epidemic.

Molnupiravir drug will be distributed to citizens aged 65 and over and immunocompromised

Molnupiravir is a drug sold under the umbrella of Levigro and specifically prevents the replication process of RNA viruses’ molecules. antiviral drug. This drug is used to treat COVID-19 in those infected with SARS-CoV-2. In our country, it is aimed to use the drug for treatment purposes in people aged 65 and over and immunocompromised, and to control the cases in this age range with vaccine + drug support.

Koca’s statement also provided information on the distribution status of the domestic vaccine. Accordingly, the domestic vaccine Turkovac has been distributed to all provinces in our country. Making a statement about the improvement in the general course of the epidemic, Koca also reported that the number of cases decreased.

Fahrettin Koca’s statements after the Science Meeting are as follows;

“It has been observed that the number of cases, which have increased recently due to the Omicron variant, has decreased. In Istanbul, where the cases from the Omicron variant are the highest, the number of cases has decreased by 62 percent in the last 10 days. This situation is similar for our other provinces. As of the beginning of the week, the number of cases started to decrease. Significant decreases are expected in the next two weeks.

There has been a decrease of 28 percent in hospitalizations in the last 1 week. There was no problem during the period when the highest number of cases were experienced without straining our health capacity. Antiviral with molnupiravir active ingredient The use of the drug has started. The distribution of the drug Molnupiravir has started to our citizens over the age of 65 and who are immunocompromised. Early initiation of the use of the drug with the active ingredient Molnupiravir significantly increases the success of the treatment. It is critical for our elders to do the test immediately and start the drug in the early period. (

Our domestic vaccine, Turkovac, was distributed to all our provinces, and distribution to the districts has begun. Two weeks later, our Turkovac vaccine will be distributed to family physicians. The use of our domestic vaccine is recommended at the highest level for all our citizens.

The protection of our citizens over the age of 65, most affected by the epidemic, is the highest priority of epidemic management. The use of the new drug and the reminder dose vaccinations will significantly reduce our losses. Our citizens may confuse the disease, which starts mildly and progresses, with colds and flu. When symptoms are detected, especially our elders should give a test sample without delay.”